Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Ribosome Profiling02:24

Ribosome Profiling

4.0K
Ribosome profiling or ribo-sequencing is a deep sequencing technique that produces a snapshot of active translation in a cell. It selectively sequences the mRNAs protected by ribosomes to get an insight into a cell’s translation landscape at any given point in time.
Applications of ribosome profiling
Ribosome profiling has many applications, including in vivo monitoring of translation inside a particular organ or tissue type and quantifying new protein synthesis levels.
The technique...
4.0K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Retina-specific long non-coding RNAs associated with inherited retinal disease genes.

Cellular and molecular life sciences : CMLS·2026
Same author

Unmasking metabolic disruptors: The NEMESIS project's quest for Novel Biomarkers, Evidence on Adverse Effects, and Efficient Methodologies.

Open research Europe·2026
Same author

Oral Immunotherapy Induces Shift in lncRNA Expression Modulating Allergen-Specific Immune Responses.

Allergy·2025
Same author

Network-based estimation of therapeutic efficacy and adverse reaction potential for prioritisation of anti-cancer drug combinations.

Computational and structural biotechnology journal·2025
Same author

Comparison of missing data handling methods for variant pathogenicity predictors.

NAR genomics and bioinformatics·2025
Same author

Corrigendum to "Composition of active bacterial communities and presence of opportunistic pathogens in disinfected and non-disinfected drinking water distribution systems in Finland" [Water Research, Volume 248 (2024) 120858].

Water research·2025

Related Experiment Video

Updated: Dec 20, 2025

Author Spotlight: Cost-Effective Transcriptomic Drug Screening - Unlocking New Targets
06:40

Author Spotlight: Cost-Effective Transcriptomic Drug Screening - Unlocking New Targets

Published on: February 23, 2024

1.7K

ThETA: transcriptome-driven efficacy estimates for gene-based TArget discovery.

Mario Failli1,2, Jussi Paananen1,3, Vittorio Fortino1,3

  • 1Institute of Biomedicine, University of Eastern Finland, Kuopio 70210, Finland.

Bioinformatics (Oxford, England)
|May 22, 2020
PubMed
Summary
This summary is machine-generated.

Estimating gene-target-disease associations for drug discovery is improved by the Transcriptome-driven Efficacy estimates for gene-based TArget discovery (ThETA) R package. ThETA enhances accuracy by integrating tissue-specific gene expression and network data for robust target identification.

More Related Videos

Using Human Differentially Expressed Gene Lists to Perform Downstream Pathway Enrichment Analysis and Target Prioritization
03:08

Using Human Differentially Expressed Gene Lists to Perform Downstream Pathway Enrichment Analysis and Target Prioritization

Published on: October 3, 2025

808
High-throughput Screening for Chemical Modulators of Post-transcriptionally Regulated Genes
09:44

High-throughput Screening for Chemical Modulators of Post-transcriptionally Regulated Genes

Published on: March 3, 2015

9.8K

Related Experiment Videos

Last Updated: Dec 20, 2025

Author Spotlight: Cost-Effective Transcriptomic Drug Screening - Unlocking New Targets
06:40

Author Spotlight: Cost-Effective Transcriptomic Drug Screening - Unlocking New Targets

Published on: February 23, 2024

1.7K
Using Human Differentially Expressed Gene Lists to Perform Downstream Pathway Enrichment Analysis and Target Prioritization
03:08

Using Human Differentially Expressed Gene Lists to Perform Downstream Pathway Enrichment Analysis and Target Prioritization

Published on: October 3, 2025

808
High-throughput Screening for Chemical Modulators of Post-transcriptionally Regulated Genes
09:44

High-throughput Screening for Chemical Modulators of Post-transcriptionally Regulated Genes

Published on: March 3, 2015

9.8K

Area of Science:

  • Genomics
  • Bioinformatics
  • Pharmacology

Background:

  • Estimating gene-target-disease associations is crucial for drug discovery.
  • Current methods using RNA expression or gene co-expression networks have limitations, including false positives and lack of tissue specificity.

Purpose of the Study:

  • Introduce Transcriptome-driven Efficacy estimates for gene-based TArget discovery (ThETA), an R package for improved drug-target discovery.
  • Provide non-expert users with novel efficacy scoring methods for identifying gene-disease associations.

Main Methods:

  • Developed the ThETA R package incorporating novel efficacy scoring methods.
  • Enabled searching for gene perturbations that reverse disease-gene expression.
  • Integrated tissue-specific gene co-expression networks.
  • Implemented functions for combining efficacy scores and building an overall score.
  • Included visualizations for tissue-specific gene interconnections and biological annotations.

Main Results:

  • ThETA facilitates the identification of gene perturbations reversing disease-gene expression.
  • The package identifies genes closely related to disease genes within tissue-specific networks.
  • ThETA integrates various efficacy evaluations to prioritize gene-disease associations.
  • Visualizations highlight tissue-specific relationships and biological relevance of top genes.

Conclusions:

  • ThETA offers a robust framework for estimating gene-target-disease associations.
  • The package enhances drug discovery by improving the accuracy and tissue specificity of target identification.
  • ThETA empowers users with advanced tools for prioritizing therapeutic targets.